Neurobots—xenobots with neurons—show self-organized nervous systems and enhanced behaviors, revealing new insights into how biology builds functional structures.
In 2020, researchers at Tufts University developed tiny living structures known as xenobots using frog cells. These microscopic organisms could move through water, repair themselves, and even gather loose cells to form new xenobots.
Scientists at Tufts and the Wyss Institute have now pushed this work further by introducing nerve cells into these biological machines. The upgraded versions, called neurobots, can take on different shapes and display new patterns of movement. The findings were recently published in Advanced Science.
Led by Michael Levin, Vannevar Bush Professor of Biology, and Haleh Fotowat of the Wyss Institute, the research is part of a broader effort to understand how groups of cells organize themselves into complex structures under unfamiliar conditions. This knowledge could support advances in synthetic biology and regenerative medicine. Studying neurobots may reveal the underlying rules that guide how nervous systems form, which could eventually help scientists design new biological structures or repair damaged tissues.
Building Living Systems from Frog Cells
The team began with cells taken from early embryos of the African clawed frog, Xenopus laevis. When precursor skin cells from these embryos are isolated and placed in a dish, they naturally assemble into small, round structures covered in tiny hair-like projections called cilia.

The coordinated motion of these cilia allows xenobots, a type of biobot, to swim through water. They are entirely biological and are created without scaffolds or genetic modification. These organisms can heal themselves and survive for about 9 to 10 days using nutrients stored in the original embryonic cells. Researchers had already studied their structure and behavior and wanted to see how adding neurons would change them, especially since these systems have no evolutionary history shaping their neural organization.
Adding Neurons: Creating Neurobots
To produce neurobots, scientists inserted clusters of neural precursor cells, which later develop into neurons, into the center of forming biobots. This was done during a brief stage when the spherical structures were still developing. The implanted cells matured and extended branching structures known as axons and dendrites throughout the interior and toward the surface.
“We wanted to find out what would happen if we provided these biobots with the raw materials needed to build a nervous system,” said Levin, director of the Allen Discovery Center at Tufts. He explained that neurobots offer a new way to study how neurons organize themselves and influence movement. “This approach is different because you now have a system with a biological body that can exhibit behavior,” said Levin.
Fotowat said the work also aims to uncover the basic principles behind how nervous systems form. “I’ve tried to understand neuronal behavior in existing animals like zebrafish and how they give rise to behavior, but neurobots are about reverse engineering. Can we build a nervous system from the start? What happens if you put neurons in a completely novel context? What are the basic, innate rules for them to organize and form networks?”
Neural Activity and Structural Changes
Microscopy showed that neurons within the neurobots developed key features found in natural nervous systems, including axons and dendrites. Researchers also detected protein markers linked to synapses, where neurons communicate. Using calcium imaging, they confirmed that these neurons were electrically active and functioning within simple neural networks.

The addition of neurons led to noticeable changes. Neurobots were generally larger and more elongated than their non-neural counterparts. Their movement also became more complex. While both types could swim, neurobots were more active and displayed repeating movement patterns instead of simple paths.
To examine how neural activity influenced behavior, scientists exposed the neurobots to pentylenetetrazole, a drug known to affect brain activity and trigger seizures. The drug altered the movement of neurobots differently than it did in non-neural biobots, suggesting that the newly formed neural networks were actively shaping behavior. This result shows that even simple, self-organized neural systems can affect how these living constructs move.
Unexpected Genetic Activity and Future Possibilities
“If you’re trying to build something new with biology, we first have to learn how cells themselves solve problems,” said Fotowat.
Researchers also observed unexpected gene activity. In addition to genes linked to major brain receptors, they found activation of genes involved in visual processing, including those associated with light-sensitive cells found in eyes. This raises the possibility that neurobots could eventually respond to light.
“We don’t know, but my hypothesis is that these neurobots are up-regulating parts of the genome that could be useful for novel functions down the line,” said Levin. “If they lived longer, would they then also develop photoreceptors? It’s a fascinating question that we are actively studying.”
Reference: “Engineered Living Systems With Self-Organizing Neural Networks: From Anatomy to Behavior and Gene Expression” by Haleh Fotowat, Laurie O’Neill, Léo Pio-Lopez, Megan M. Sperry, Patrick Erickson, Tiffany Lin and Michael Levin, 20 February 2026, Advanced Science.
DOI: 10.1002/advs.202508967
This study was funded by the U.S. Department of Defense, the John Templeton Foundation, and Northpond Ventures.
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]
Beyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth Model
At a moment when AI is forcing a fundamental rethink of how work gets done, the life sciences industry is grappling with a deeper question: what role should human creativity play in an increasingly [...]
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]















